|
|
For Healthcare
Professionals
|
|
|
|
|
Mechanism of Action
Although the exact mechanism of action is unknown, Ganite is believed to exert a hypocalcemic
effect by inhibiting calcium resorption from bone:
-
Gallium nitrate localizes preferentially where bone resorption and remodeling is occurring
11
-
Gallium nitrate inhibits osteoclast activity
12,
13
- Inhibition of resorption may occur via a reduction in increased bone turnover
Preclinical evidence suggests that the mechanism of action of gallium nitrate is multifaceted
14
and differs from other hypocalcemic therapies, including the bisphosphonates
13,
15
Although in vitro and animal studies have been performed to investigate the mechanism of action of
the drug, the precise mechanism for inhibiting calcium resorption has not been fully described.
As a result, the relevance to human physiology and clinical significance of these findings is
speculative.
In vitro and animal studies suggest the following possible mechanisms:
- Inhibition of bone resorption
-
Inhibition of osteoclast activity
12,
13,
15
without general metabolic inhibition
11,
13,
15
-
Increased resistance to osteoclast-mediated resorption via enhancement of hydroxyapatite
crystallization and reduction of bone mineral solubility
11,
17-20
- Effects on bone
-
Increases calcium and phosphorous deposition into bone
11,
17,
18
-
Increases bone formation
21
-
May increase collagen synthesis
22
-
Not cytotoxic to bone cell
10,
12,
15
|
|
|
|